- Home
- BCG vs TPST Comparison
BCG vs TPST Comparison
Compare BCG & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCG
- TPST
- Stock Information
- Founded
- BCG 2016
- TPST 2011
- Country
- BCG United States
- TPST United States
- Employees
- BCG N/A
- TPST N/A
- Industry
- BCG
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- BCG
- TPST Health Care
- Exchange
- BCG Nasdaq
- TPST Nasdaq
- Market Cap
- BCG 32.5M
- TPST 33.0M
- IPO Year
- BCG N/A
- TPST N/A
- Fundamental
- Price
- BCG $2.00
- TPST $7.49
- Analyst Decision
- BCG
- TPST Hold
- Analyst Count
- BCG 0
- TPST 3
- Target Price
- BCG N/A
- TPST $30.00
- AVG Volume (30 Days)
- BCG 24.6K
- TPST 93.8K
- Earning Date
- BCG 08-14-2025
- TPST 08-11-2025
- Dividend Yield
- BCG N/A
- TPST N/A
- EPS Growth
- BCG N/A
- TPST N/A
- EPS
- BCG N/A
- TPST N/A
- Revenue
- BCG $172,860,000.00
- TPST N/A
- Revenue This Year
- BCG N/A
- TPST N/A
- Revenue Next Year
- BCG N/A
- TPST N/A
- P/E Ratio
- BCG N/A
- TPST N/A
- Revenue Growth
- BCG 7.36
- TPST N/A
- 52 Week Low
- BCG $1.71
- TPST $5.35
- 52 Week High
- BCG $6.55
- TPST $28.34
- Technical
- Relative Strength Index (RSI)
- BCG N/A
- TPST 55.53
- Support Level
- BCG N/A
- TPST $7.13
- Resistance Level
- BCG N/A
- TPST $8.75
- Average True Range (ATR)
- BCG 0.00
- TPST 0.51
- MACD
- BCG 0.00
- TPST 0.10
- Stochastic Oscillator
- BCG 0.00
- TPST 52.27
About BCG Binah Capital Group Inc. Common Stock
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.